tiprankstipranks
Prime Medicine, Inc. (PRME)
:PRME
US Market

Prime Medicine, Inc. (PRME) Income Statement

Compare
614 Followers

Prime Medicine, Inc. Income Statement

Last quarter (Q4 2024), Prime Medicine, Inc.'s total revenue was $2.18M, an increase of Infinity% from the same quarter last year. In Q4, Prime Medicine, Inc.'s net income was $-42.28M. See Prime Medicine, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.98M$ 0.00$ 0.00$ 0.00$ 5.21M
Gross Profit
$ 2.98M$ -147.91M$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 205.45M$ 186.64M$ 116.54M$ 84.47M$ 6.14M
Depreciation and Amortization
$ 0.00$ 4.65M$ 12.01M$ 4.86M$ 43.00K
EBITDA
$ -202.47M$ -193.76M$ -110.75M$ -160.99M$ -889.00K
Operating Income
$ -202.47M$ -191.29M$ -116.54M$ -84.47M$ -932.00K
Other Income/Expenses
$ 6.58M$ -7.12M$ -6.22M$ -81.38M$ -611.00K
Pretax Income
$ -195.88M$ -198.41M$ -122.77M$ -165.85M$ -1.54M
Net Income
$ -195.88M$ -198.13M$ -121.82M$ -165.37M$ -3.41M
Per Share Metrics
Basic EPS
$ -1.65$ -2.18$ -1.25$ -2.55$ -0.07
Diluted EPS
$ -1.65$ -2.18$ -1.25$ -2.55$ -0.07
Weighted Average Shares Outstanding
118.60M 90.97M 97.21M 64.90M 71.80M
Weighted Average Shares Outstanding (Diluted)
118.60M 90.97M 97.21M 64.90M 71.80M
Currency in USD

Prime Medicine, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis